Summary:
Psychiatric Care and Research Center is conducting a multi-center, randomized, double-blind, placebo-controlled study to investigate the potential weight gain, or lack of weight gain, of a combination of olanzapine and samidorphan compared to olanzapine in adults with schizophrenia. This is a new combination medication to control weight gain while also treating the symptoms of schizophrenia.
Qualified Participants Must:
• Be diagnosed with Schizophrenia
•
Be between 18 and 55 years of age
•
Have a BMI (Body Mass Index) between 18 and 30
•
Have no hospitalizations for their illness within the past 6 months
•
Not have been on Zyprexa within the past 6 months
- No substance abuse within the last 3 months
Qualified Participants May Receive:
Compensation for time and travel may be possible.
Complete physical examination.